COMMUNIQUÉS West-GlobeNewswire

Le KFSHRC propose des programmes de recherche innovants aux futurs leaders du secteur de la santé
24/08/2024
RIYAD, Arabie saoudite, 24 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) renforce sa position de leader dans l’éducation et la recherche médicale grâce à son Département [...]
Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies
24/08/2024
NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen TOKYO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Koji Eguchi; listed on [...]
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24/08/2024
SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced [...]
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
23/08/2024
FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications [...]
Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q
23/08/2024
BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of [...]
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
23/08/2024
FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced [...]
Cingulate Announces Adjournment of Special Meeting
23/08/2024
KANSAS CITY, Kan., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), (“Cingulate” or the “Company”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery [...]
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction
23/08/2024
This release has made a correction to a release issued under the same headline on August 14, 2024, by HCW Biologics, Inc. (NASDAQ: HCWB), to show the amount included in the condensed interim balance sheet for Cash and [...]
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/08/2024
BRISBANE, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated therapeutics to fight cancer [...]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23/08/2024
CAMBRIDGE, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
23/08/2024
PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ( NASDAQ : OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that [...]
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
23/08/2024
WESTMINSTER, Colo., Aug. 23, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced that its Board of Directors (the “Board”) has approved a reverse stock split of ARCA’s common stock at a [...]
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome
23/08/2024
SciSparc to conduct the trial at the Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel TEL AVIV, Israel, Aug. 23, 2024 ( [...]
NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences
23/08/2024
Participation in the events in Boston and New York highlights the Company's prominence in regenerative medicine and exosome technology TORONTO and HAIFA, Israel, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc [...]
Sienna Senior Living Inc. Announces DBRS Credit Rating Update
23/08/2024
MARKHAM, Ontario, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced the confirmation by Dominion Bond Rating Service (“DBRS”) of the Company’s BBB Issuer [...]
bioLytical Announces Final Results of Substantial Issuer Bid
23/08/2024
VANCOUVER, British Columbia, Aug. 23, 2024 (GLOBE NEWSWIRE) -- bioLytical Laboratories Inc. (the “Company” or “bioLytical”) announces that it has taken up and paid for 18,234,667 common shares (the “Purchased Shares”) [...]
NMDP Named ‘Best Place to Work’ Fourth Year in a Row
23/08/2024
Global cell therapy nonprofit honored in top 3 of the 'extra large' companies, recognizing its exceptional employees, workplace culture and life-saving mission MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NMDP SM , a [...]
Sienna Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus
23/08/2024
Final Short Form Prospectus is Accessible on SEDAR+ NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc [...]
Fagron’s share buy-back program: Weekly update
23/08/2024
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 23 August 2024 – 6PM CET Fagron’s share buy-back program: Weekly update In the period from 19 August 2024 through 23 August 2024, Fagron purchased 34 [...]

Pages